|
1
|
Li J, Fu R, Yang L and Tu W: miR-21
expression predicts prognosis in diffuse large B-cell lymphoma. Int
J Clin Exp Pathol. 8:15019–15024. 2015.PubMed/NCBI
|
|
2
|
Ma M, Zhao L, Sun G, Zhang C, Liu L, Du Y,
Yang X and Shan BE: Mda-7/IL-24 enhances sensitivity of B cell
lymphoma to chemotherapy drugs. Oncol Rep. 35:3122–3130. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang BX, Duan YJ, Dong CY, Zhang F, Gao
WF, Cui XY, Lin YM and Ma XT: Novel functions for mda-7/IL-24 and
IL-24 delE5: Regulation of differentiation of acute myeloid
leukemic cells. Mol Cancer Ther. 10:615–625. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong CY, Zhang F, Duan YJ, Yang BX, Lin YM
and Ma XT: mda-7/IL-24 inhibits the proliferation of hematopoietic
malignancies in vitro and in vivo. Exp Hematol. 36:938–946. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hosseini E, Hosseini SY, Hashempour T,
Fattahi MR and Sadeghizadeh M: Effect of RGD coupled MDA-7/IL-24 on
apoptosis induction in a hepatocellular carcinoma cell line. Mol
Med Rep. 15:495–501. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huo W, Li ZM, Zhu XM, Bao YM and An LJ:
MDA-7/IL-24 suppresses tumor adhesion and invasive potential in
hepatocellular carcinoma cell lines. Oncol Rep. 30:986–992. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma M, Yang X, Zhao L, Liu L, Zhang C, Wang
X and Shan B: Mda-7/IL-24 induces the differentiation of B cell
lymphoma via activation of the P38 mitogen activated protein kinase
signaling pathway. Mol Med Rep. 16:5633–5642. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu X, Zhou H, Huang X, Cui J, Long T, Xu
Y, Liu H, Yu R, Zhao R, Luo G, et al: A broad blockade of signaling
from the IL-20 family of cytokines potently attenuates
collagen-induced arthritis. J Immunol. 197:3029–3037. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Panneerselvam J, Srivastava A,
Muralidharan R, Wang Q, Zheng W, Zhao L, Chen A, Zhao YD, Munshi A
and Ramesh R: IL-24 modulates the high mobility group (HMG)
A1/miR222/AKT signaling in lung cancer cells. Oncotarget.
7:70247–70263. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Piovesan D, Tempany J, Di Pietro A, Baas
I, Yiannis C, O'Donnell K, Chen Y, Peperzak V, Belz GT, Mackay CR,
et al: c-Myb regulates the T-bet-dependent differentiation program
in B cells to coordinate antibody responses. Cell Rep. 19:461–470.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iżykowska K, Przybylski GK, Gand C, Braun
FC, Grabarczyk P, Kuss AW, Olek-Hrab K, Bastidas Torres AN, Vermeer
MH, Zoutman WH, et al: Genetic rearrangements result in altered
gene expression and novel fusion transcripts in Sézary syndrome.
Oncotarget. 8:39627–39639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jaffe ES: The 2008 WHO classication of
lymphomas: Implications for clinical practice and translational
research. Hematology Am Soc Hematol Educ Program. pp. 523–531.
2009, PubMed/NCBI
|
|
13
|
Zelenetz AD, Gordon LI, Wierda WG,
Abramson JS, Advani RH, Andreadis CB, Bartlett N, Byrd JC, Czuczman
MS, Fayad LE, et al: Non-Hodgkin's lymphomas, version 4.2014. J
Natl Compr Canc Netw. 12:1282–1303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu SL, Oshima T, Imada T, Musuda M,
Debnath B, Grande F, Garofalo A and Neamati N: Stabilization of
MDA-7/IL-24 for colon cancer therapy. Cancer Lett. 335:421–430.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Wang Z, Dai X, Pan J, Ge J, Han X,
Wu Z, Zhou X and Zhao T: Re-expression of microRNA-150 induces
EBV-positive Burkitt lymphoma differentiation by modulating c-Myb
in vitro. Cancer Sci. 104:826–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cheng HR, Wu BQ, Chen L, Zhang ZX and Li
B: Expression and effect of serum interleukin-24 level on bone
marrow mononuclear cells in children with acute leukemia. Genet Mol
Res. 14:17281–17288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patani N, Douglas-Jones A, Mansel R, Jiang
W and Mokbel K: Tumour suppressor function of MDA-7/IL-24 in human
breast cancer. Cancer Cell Int. 10:292010.PubMed/NCBI
|
|
18
|
Galimova E, Rätsep R, Traks T, Kinggo K,
Escott-price V and Kõks S: Interleukin-10 family cytokines pathway:
Genetic variants and psoriasis. Br J Dermatol. 176:1577–1587. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sang M, Hulsurkar M, Zhang X, Song H,
Zheng D, Zhang Y, Xu J, Zhang S, Ittmann M and Li W: GRK3 is a
direct target of CREB activation and regulates neuroendocrine
differentiation of prostate cancer cells. Oncotarget.
7:45171–45185. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia Y, Xu-Monette ZY, Tzankov A, Li X,
Manyam GC, Murty V, Bhagat G, Zhang S, Pasqualucci L, Visco C, et
al: Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of
activated B-cell-like diffuse large B-cell lymphoma. Leukemia.
31:625–636. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chan YH, Chiang MF, Tsai YC, Su ST, Chen
MH, Hou MS and Lin KI: Absence of the transcriptional repressor
Blimp-1 in hematopoietic lineages reveals its role in dendritic
cell homeostatic development and function. J Immunol.
183:7039–7046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pradhan AK, Talukdar S, Bhoopathi P, Shen
XN, Emdad L, Das SK, Sarkar D and Fisher PB: Mda-7/IL-24 mediates
cancer cell-specific death via regulation of miR-221 and the
beclin-1 axis. Cancer Res. 77:949–959. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma YF, Ren Y, Wu CJ, Zhao XH, Xu H, Wu DZ,
Xu J, Zhang XL and Ji Y: Interleukin (IL)-24 transforms the tumor
microenvironment and induces anticancer immunity in a murine model
of colon cancer. Mol Immunol. 75:11–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv C, Su Q, Liang Y, Hu J and Yuan S:
Oncolytic vaccine virus harbouring the IL-24 gene suppresses the
growth of lung cancer by inducing apoptosis. Biochem Biophys Res
Commun. 476:21–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
